PZU Zdrowie (Health)Thin moat

PZU (PZU) — moat facet

Clinics and health plans — the recurring franchise growing fastest inside the group.

PZU Zdrowie, the group's health arm, is the youngest and fastest-growing leg of the distribution moat, and a genuinely attractive one. It combines health-insurance products with an owned-and-partnered network of medical clinics, riding a powerful long-term trend: as Poland grows wealthier and its public health service strains, more Poles and their employers pay for private medical cover and care. That demand is recurring, growing, and relatively price-insensitive — a much better set of economics than commodity motor.

Health pillar revenue (zl m)1 89020242 16220251 051H1 20251 161H1 2026PZU results presentations for 2025 and 1H26
Health grew 14% in 2025 and 10% in the first half of 2026: growing, and slowing.

For PZU the health business is doubly valuable. It is a growth engine in its own right, expanding faster than the mature insurance lines, and it is a deepening of the customer relationship: a family that gets its medical plan, its life cover, and its car insurance from the same group is a stickier, more valuable customer than one who buys a single policy. Health is where PZU most resembles a growing services franchise rather than a mature commodity insurer, and it is a real, if still modest, widener of the overall moat — provided the group can build clinic capacity and manage medical-cost inflation as it scales — with a 234% Solvency II ratio giving it the capital to try1.

Moat trajectory: Widening

Widening. Private health is the group's fastest-growing, most recurring, least-commoditized leg, riding rising Polish wealth and a strained public system — a genuine, if still modest, widener of the franchise.

The number that tests this moat
Reported
Telemedicine delivered on PZU's own infrastructure
95% (2025)

Owning the clinics and the telemedicine centre lets PZU control the medical claims it would otherwise pay out. A falling share would mean more care bought from outside providers at their prices.

Source: Poland Insight, PZU 2025 results ↗
⚠ Threats to the moat
References
  1. ReportedA 234% Solvency II ratio gives capital to try.
    PZU FY2025 annual results — record net profit ~6,7bn zł (+25%), ROE >20%, Solvency II 234%, dividend 4,47 zł/share (~7% yield) — FY2025 · publ. March 2026 · source ↗
Sources
Generated September 24, 2026